Fast Field-Cycling MRI (FFC-MRI) is a novel magnetic resonance imaging technique, pioneered at the University of Aberdeen, which involves breaking one of the fundamental "laws" of MRI - that the applied magnetic field must be held constant during image acquisition. By deliberately switching the magnetic field during the collection of MR images, FFC-MRI is able to gain access to radically new types of endogenous contrast. It is already showing strong potential in the diagnosis and monitoring of a wide range of conditions, including stroke, osteoarthritis and cancer, and the world’s first patients have recently been scanned using a prototype scanner at the University of Aberdeen.
The aim of the “IDentIFY” project is to conduct research that will bring FFC-MRI closer to widespread use in hospitals and research centres. The project’s nine-team consortium is working on diverse aspects of FFC-MRI, including theory, modelling, technology, contrast agents, magnetics and clinical applications. It has received €6.60 million from the EU’s Horizon-2020 science funding scheme and runs from January 2016 to December 2019.
This one-day Symposium is being held to mark the mid-point of the IDentIFY project. Its objective is to inform stakeholders and potential beneficiaries about the current status of FFC-MRI and to indicate its future direction and potential capabilities for enhancing the diagnosis and staging of disease, as well as the monitoring of treatment. In addition, lectures will be given by the leaders of three other Horizon-2020 projects related to magnetic resonance.